Maysa I. farghly

ORCID: 0009-0006-3226-9372
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes and associated disorders
  • Diet, Metabolism, and Disease
  • Diabetes Management and Research
  • Inflammatory Biomarkers in Disease Prognosis
  • Artificial Intelligence in Healthcare and Education
  • Immune Cell Function and Interaction
  • Hematological disorders and diagnostics
  • COVID-19 Clinical Research Studies
  • Liver Disease Diagnosis and Treatment
  • Cardiovascular Disease and Adiposity
  • Pancreatic function and diabetes
  • Hormonal Regulation and Hypertension
  • MicroRNA in disease regulation
  • Liver Disease and Transplantation
  • COVID-19 diagnosis using AI
  • Advanced Glycation End Products research

Suez University
2022-2025

Abstract Background ChatGPT, a chatbot launched by OpenAI in November 2022, has generated both excitement and concern within the healthcare education, research, practice communities. This study aimed to explore knowledge, perceptions, attitudes, practices of undergraduate medical students regarding use ChatGPT similar chatbots their academic work. Methods An anonymous, structured questionnaire was developed using Google Forms administered as part cross-sectional study. The survey targeted...

10.1186/s12909-025-06731-9 article EN cc-by BMC Medical Education 2025-02-05

Studies have associated advanced glycation end-products (AGEs) and the polymorphism of AGEs receptor (RAGE) gene with clinical disorders, such as diabetes, in certain ethnic groups. However, its association type 1 diabetes mellitus (T1DM) Egyptians has not yet been explored. The aim this study was to investigate between RAGE rs1800625 T1DM susceptibility Egyptians. A case-control conducted 177 patients age- sex-matched healthy controls. Variables included glycemic markers (fasting blood...

10.52225/narra.v5i1.1603 article EN cc-by-nc Narra J 2025-01-30

<title>Abstract</title> Background Nonalcoholic fatty liver disease (NAFLD) is a common metabolic disorder intricately linked to diabetes and thyroid dysfunction. Hypothyroidism, characterized by elevated thyroid-stimulating hormone (TSH), may disrupt lipid metabolism exacerbate insulin resistance, contributing NAFLD progression. Investigating the combined impact of dysfunction on fibrosis steatosis stages in essential for optimizing management. Methods This prospective cross-sectional study...

10.21203/rs.3.rs-5856889/v1 preprint EN cc-by Research Square (Research Square) 2025-02-03

Type I diabetes mellitus (T1DM) is one of the most common chronic autoimmune diseases worldwide. miRNAs are a class small non-coding RNA molecules that have been linked to immune system functions, β-cell metabolism, proliferation, and death, all which contribute pathogenesis TIDM. Dysregulated identified in Egyptian TIDM patients. Several were profiled patients determine whether they can be used as molecular biomarkers for T1DM. The relationship between investigated pro-inflammatory...

10.1016/j.ncrna.2024.06.001 article EN cc-by-nc-nd Non-coding RNA Research 2024-06-20
Coming Soon ...